Fundamental index

600671.SS Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd

Healthcare · Drug Manufacturers - General · CN · as of 2026-09-08

E
Fundamental score
31.29

Reasons

  • Quality 46: ROE 23.9%, ROIC n/a, net margin 8.0%
  • Balance 37: debt/equity n/a, current ratio 0.84, Altman Z 3.76
  • Cash flow 0: OCF/share 0.02, FCF/share -0.23

Risk flags

negative FCF/share -0.23

Component scores

Quality46
Growth50
Balance37
Valuation0
Cash flow0

Key metrics

ROE
23.9% higher is usually better
-10%35%+
weak < 0%ok >= 10%strong >= 20%
ROICn/a
Net margin
8.0% higher is usually better
-10%35%+
weak < 0%ok >= 10%strong >= 20%
Revenue growthn/a
Debt / equityn/a
Current ratio
0.84 above 1 is generally healthier
03+
risk < 1.0ok >= 1.0strong >= 2.0
Altman Z-score
3.76 higher usually means lower distress risk
04+
distress < 1.8grey 1.8-3.0safer > 3.0
PE ration/a
EV / EBITDAn/a
FCF yield
-1.1% higher cash-flow yield is usually better
-5%15%+
weak < 0%ok >= 3%strong >= 8%

Revenue

358.47M 108.91M 358.47M 297.07M 206.63M 147.07M 108.91M 121.78M 217.30M 210.66M 2018 2019 2020 2021 2022 2023 2024 2025

X-axis: fiscal years from cached FMP annual statement data. Y-axis: revenue values.

Net income

50.68M -67.52M -9.88M 50.68M -40.52M -29.80M -67.52M -38.28M 15.25M 17.62M 2018 2019 2020 2021 2022 2023 2024 2025

X-axis: fiscal years from cached FMP annual statement data. Y-axis: net income values.

Free cash flow

66.47M -57.23M 33.24M 66.47M -20.23M -31.13M -22.89M -29.38M -57.23M -19.38M 2018 2019 2020 2021 2022 2023 2024 2025

X-axis: fiscal years from cached FMP annual statement data. Y-axis: free cash flow values.

Growth metrics

103.2% -30.4% 103.2% -17.1% -30.4% -28.8% -25.9% 11.8% 78.4% -3.1% 2018 2019 2020 2021 2022 2023 2024 2025

X-axis: fiscal years from cached FMP annual statement data. Y-axis: growth metrics values.

Abbreviations and definitions

ROE
ROE measures how much net profit a company generates from shareholders' equity.
ROIC
ROIC compares operating profit after tax with the capital invested in the business.
Net margin
Net margin shows how much net profit remains from revenue.
Revenue growth
Revenue growth measures how sales changed versus the comparable prior period.
Debt / equity
Debt to equity compares company debt with shareholders' equity.
Current ratio
Current ratio compares short-term assets with short-term liabilities.
Altman Z-score
Altman Z-score is a model estimating bankruptcy risk from financial ratios.
PE ratio
PE compares market price with earnings per share.
EV / EBITDA
EV/EBITDA compares total company value with operating earnings before depreciation and amortization.
FCF yield
FCF yield compares free cash flow with market value.
Revenue
Revenue is the total amount generated from selling goods or services before expenses.
Net income
Net income is profit after operating costs, interest, taxes and other expenses.
Free cash flow
Free cash flow is cash left after operating cash flow covers capital expenditures.
Growth metrics
Growth metrics summarize changes in revenue, profit or EPS versus a prior period.
EPS
EPS is net income allocated to each share.
EBITDA
EBITDA is earnings before interest, taxes, depreciation and amortization.
TTM
TTM is a rolling last-12-month view instead of one fiscal year.

This page is an automated factual summary of cached FMP data, not investment advice. Always verify source filings and liquidity before making decisions.